Swertiamarin supplementation prevents obesity-related chronic inflammation and insulin resistance in mice fed a high-fat diet

Obesity is characterized by low-grade chronic inflammation, which underlies insulin resistance and non-alcoholic fatty liver disease (NAFLD). Swertiamarin is a secoiridoid glycoside that has been reported to ameliorate diabetes and NAFLD in animal models. However, the effects of swertiamarin on obes...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Liang, Li, Dandan, Zhu, Yuqin, Cai, Suili, Liang, Xue, Tang, Ying, Jin, Shengnan, Ding, Chunming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023247/
https://www.ncbi.nlm.nih.gov/pubmed/33794740
http://dx.doi.org/10.1080/21623945.2021.1906510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023247/
https://www.ncbi.nlm.nih.gov/pubmed/33794740
http://dx.doi.org/10.1080/21623945.2021.1906510

Ejemplares similares